Legionella Testing Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Legionella Testing Market size was valued at around USD 316.8 million in 2023 and is anticipated to register a CAGR of around 8.6% between 2024 and 2032. Legionella testing refers to the process of detecting and identifying legionella bacteria in various environments, including water systems, clinical specimens, and other potential sources of contamination.
The increasing prevalence of pneumonia and legionella-related illnesses has become a major public health concern worldwide. Legionella bacteria, especially Legionella pneumophila, can cause severe respiratory infections such as Legionnaires' disease and Pontiac fever. For instance, as per the World Health Organization (WHO), in Europe, Australia, and the U.S., an estimated 10–15 cases are detected per million population each year. Among these reported cases, individuals over 50 years old account for 75–80%, while males make up 60–70% of the affected population.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Legionella Testing Market size in 2023: | USD 316.8 Million |
Forecast Period: | 2024 - 2032 |
Forecast Period 2023 - 2032 CAGR: | 8.6 |
2023 Value Projection: | USD 659.4 Million |
Historical Data for: | 2018 - 2023 |
No of Pages: | 201 |
Tables, Charts & Figures: | 339 |
Segments Covered: | Test Type, Application, End-use, and Region |
Growth Drivers: |
|
Pitfalls Challenges: |
|
Furthermore, governments and regulatory bodies around the world have implemented stringent regulations and guidelines for regular water testing, especially in high-risk environments such as healthcare facilities, hotels, nursing homes, and industrial settings. These regulations mandate the implementation of comprehensive water management plans, including routine legionella testing, to mitigate the risk of legionella contamination and protect public health.
Based on test type, the market is segmented into culture methods, urinary antigen test (UAT), serology, direct fluorescent antibody test (DFA), polymerase chain reaction (PCR) testing, and other test types. The culture methods segment is estimated to account for USD 200.8 million by 2032.
Based on application the legionella testing market is segmented into water testing, invitro diagnostics (IVD)testing [which is estimated to reach USD 141 billion by 2032], and other applications. The water testing segment accounted for USD 193.6 million in 2023.
Based on end-use, the legionella testing market is segmented into hospital and clinics, water treatment plants, diagnostic laboratories, and other end-users. The water treatment plants segment held the largest business share of 45.3% in 2023. This substantial share can be attributed to the critical role that water treatment plants play in ensuring the safety and purity of water supplies by treating water from various sources.
In 2023, North America held a significant business share of 40.6% in the global legionella testing market and is predicted to witness substantial market growth over the analysis timeline.
The legionella testing industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products based on different technologies is among a key market strategy. Some of the leading industry players including Bio-Rad Laboratories, Inc, Abbott Laboratories, Thermo Fisher Scientific Inc among others have a notable presence in the market.
Some of the eminent market participants operating in the legionella testing industry include:
Market, By Test Type
Market, By Application
Market, By End-use
The above information is provided for the following regions and countries:
North America recorded 40.6% of the legionella testing industry share in 2023 and is predicted to witness substantial growth through 2032 as the region has a robust healthcare infrastructure and regulatory framework that emphasizes the importance of legionella testing for public health and safety.
Abbott Laboratories, Becton, Dickinson & Company, Biomerieux, Bio-Rad Laboratories Inc., Danaher Corporation, IDEXX Laboratories Inc, Merck KGaA, Pro-lab Diagnostics Inc., QIAGEN N.V., and Thermo Fisher Scientific Inc.
Global legionella testing industry was valued at USD 316.8 million in 2023 and is estimated to reach over USD 659.4 million by 2032 attributed to the increasing prevalence of pneumonia and legionella-related illnesses.
Water legionella testing industry accounted for USD 193.6 million in 2023 and will grow significantly through 2032 attributed to the heightened awareness surrounding legionella-related illnesses, such as legionnaires' disease.